comparemela.com

Latest Breaking News On - Professor nico karssemeijer - Page 1 : comparemela.com

Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk

Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands

ScreenPoint Medical: Transpara® Breast AI demonstrates value in real-world clinical usage

Q1 growth and clinically relevant research outcomes followed by milestone - over 4 million mammograms analyzed. NIJMEGEN, Netherlands, May 2, 2023 /PRNewswire/ ScreenPoint Medical announced

Transpara AI Breast Care - Global Expansion planned for 2022

/PRNewswire/ Following the success of the world s leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide,.

New publication proves that Transpara by ScreenPoint Medical helps radiologists improve their accuracy with 3D mammography

New publication proves that Transpara by ScreenPoint Medical helps radiologists improve their accuracy with 3D mammography Share Article More peer reviewed evidence demonstrates that Transpara not only improves Radiologists accuracy but also helps to speed up reading time of 3D mammograms Transpara is like having a colleague providing a second opinion, I use it routinely for clinical mammography when in doubt. NIJMEGEN, Netherlands (PRWEB) May 12, 2021 Another key publication, this time in the European Radiology journal, shows the benefits of using Transpara breast AI with 3D mammography. Here are the key findings from the publication by S L van Winkel, A Rodríguez-Ruiz, L Appelman, A Gubern-Mérida, N Karssemeijer, J Teuwen, A J T Wanders, I Sechopoulos, R M Mann. Impact of artificial intelligence support on accuracy and reading time in breast tomosynthesis image interpretation: a multi-reader multi-case stu

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.